These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29878685)

  • 1. Session 3: Beyond TME and radiotherapy MRI evaluation of rectal cancer treatment response.
    Patel UB; Blomqvist L; Chau I; Nicholls J; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():76-81. PubMed ID: 29878685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Session 4: What should we do for poor responders after chemoradiotherapy: bad biology or should the fight go on?
    Bhoday J; Glimelius B; Tait D; Glynne-Jones R; Adams R; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():97-99. PubMed ID: 29878687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Session 2: Are we ready for primary chemotherapy in rectal cancer: who, when, why?
    Patel UB; Cervantes A; Fernández-Martos C; Sclafani F; Cunningham D; Nilsson P; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():56-60. PubMed ID: 29878678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Session 4: Shaping radiotherapy for rectal cancer: should this be personalized?
    Dattani M; Marijnen C; Moran B; Tait D; Cunningham C; Rodriguez-Bigas M; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():92-96. PubMed ID: 29878670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
    Ryan JE; Warrier SK; Lynch AC; Heriot AG
    Colorectal Dis; 2015 Oct; 17(10):849-61. PubMed ID: 26260213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Locoregional Rectal Cancer.
    Willett CG
    J Natl Compr Canc Netw; 2018 May; 16(5S):617-619. PubMed ID: 29784739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.
    Nguyen P; Wuthrick E; Chablani P; Robinson A; Simmons L; Wu C; Arnold M; Harzman AE; Husain S; Schmidt C; Abdel-Misih S; Bekaii-Saab T; Chakravarti A; Williams TM
    Am J Clin Oncol; 2018 Feb; 41(2):140-146. PubMed ID: 26535992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response assessment after (chemo)radiotherapy for rectal cancer: Why are we missing complete responses with MRI and endoscopy?
    van der Sande ME; Beets GL; Hupkens BJ; Breukink SO; Melenhorst J; Bakers FC; Lambregts DM; Grabsch HI; Beets-Tan RG; Maas M
    Eur J Surg Oncol; 2019 Jun; 45(6):1011-1017. PubMed ID: 30528891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
    Wang Y; Chen G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Session 4: Trying to augment response with chemotherapy: a triumph of hope over experience?
    Battersby NJ; Perez RO; Baxter N; Moran B; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():100-102. PubMed ID: 29878682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Session 3: Beyond the boundaries of Total Mesorectal Excision - where surgeons fear to tread.
    Patel A; Holm T; Wale A; Rutten H; Nicholls J; Hawkins M; Steele RJC; Marks J; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():61-64. PubMed ID: 29878672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer.
    Suppiah A; Hunter IA; Cowley J; Garimella V; Cast J; Hartley JE; Monson JR
    Colorectal Dis; 2009 Mar; 11(3):249-53. PubMed ID: 18513192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted MRI for Diagnosing Extramural Venous Invasion in Rectal Cancer after Neoadjuvant Therapy: A Prognostic Biomarker.
    Méndez RJ; Ayuso JR
    Radiology; 2023 Aug; 308(2):e231661. PubMed ID: 37581500
    [No Abstract]   [Full Text] [Related]  

  • 15. Session 3: Many ways to organ preserve the rectum but which is correct?
    Read J; Tekkis P; Rullier E; Nicholls J; Mortensen N; Marks J; Steele RJC; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():82-87. PubMed ID: 29878680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease.
    Barbaro B; Leccisotti L; Vecchio FM; Di Matteo M; Serra T; Salsano M; Poscia A; Coco C; Persiani R; Alfieri S; Gambacorta MA; Valentini V; Giordano A; Bonomo L
    Br J Radiol; 2017 Jan; 90(1069):20150836. PubMed ID: 27845566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of pre-treatment locoregional rectal cancer staging in a national improvement project.
    Op de Beeck B; Smeets P; Penninckx F; Pattyn P; Silversmit G; Van Eycken E;
    Acta Chir Belg; 2017 Apr; 117(2):104-109. PubMed ID: 27881048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness Analysis of Total Neoadjuvant Therapy Followed by Radical Resection Versus Conventional Therapy for Locally Advanced Rectal Cancer.
    Wright ME; Beaty JS; Thorson AG; Rojas R; Ternent CA
    Dis Colon Rectum; 2019 May; 62(5):568-578. PubMed ID: 30964794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative neo-adjuvant therapy for curable rectal cancer--reaching a consensus 2008.
    Scott NA; Susnerwala S; Gollins S; Myint AS; Levine E
    Colorectal Dis; 2009 Mar; 11(3):245-8. PubMed ID: 18637934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Session 3: Boosting primary and recurrent rectal cancer: how far can we push the radiotherapy envelope?
    Balyasnikova S; Vuong T; Wale A; Chong I; Rutten H; Brown G
    Colorectal Dis; 2018 May; 20 Suppl 1():88-91. PubMed ID: 29878674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.